A Report on Non-Ionizing Radiation

GSMA: Microwave News Article Archive (2004 - )

June 1, 2012

The Bioelectromagnetics Society (BEMS) is trying to drum up support for its annual conference, which will be held in Brisbane, Australia, later this month. For those truly committed to advancing EM health research —the stated ethos of the society— it's a tough sell. Here's a list of the sponsors of the meeting, in descending order of their level of support:...

May 18, 2012

Dead in the Water

We haven't posted many new items recently because we've been too busy fixing up the new Web site. In the process, we've been rereading many of our old stories. Last night, we came across an item from five years ago under the title "Cell Specific Responses to RF." It highlighted some new research from Finland, which found that cell phone radiation affected the activity of ODC, a biologically important enzyme, in...

July 30, 2007

Repacholi: Half of WHO EMF Project Funding Came from Industry

Mike Repacholi has now revealed that up to half of the funds raised for his EMF Project came from industry. This admission comes in an interview with Resource Strategies Inc. in an effort, he states, to “set the record straight.” Repacholi is circulating the text of the interview far and wide because, he says, he wants “the truth about WHO” to be known.

November 13, 2006

It’s Official: Mike Repacholi Is an Industry Consultant And He’s Already in Hot Water

Just months after leaving his post as the head of the EMF project at the World Health Organization (WHO), Mike Repacholi is now in business as an industry consultant. The Connecticut Light and Power Co. (CL&P), a subsidiary of Northeast Utilities, and the United Illuminating Co. (UI) have hired Repacholi to help steer the Connecticut Siting Council away from a strict EMF exposure standard.

The siting council is in the process of revising the state's EMF policies. Last year, it hired its own consultant, Peter Valberg of the Gradient Corp., to review the current state of EMF health research. Valberg's report, submitted in January, proposes a "screening level" of 100 mG to protect against any adverse health effects "even in a hypothetically more sensitive sub-population" —that is, it would also protect young children. (What's a screening level? See below.)